Altar Rock’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$629K Sell
7,802
-2,744
-26% -$161K 0.96% 20
2026
Q2
$404K Sell
10,546
-10,041
-49% -$263K 0.59% 29
2026
Q1
$437K Buy
20,587
+830
+4% +$16.6K 0.51% 29
2025
Q4
$322K Hold
19,757
– – 0.39% 45

Other funds holding TXG

Altar Rock's TXG Position: Q3 2026 in Review

Altar Rock reduced its 10x Genomics (TXG) stake by 26% in Q3 2026, selling an estimated $161K and leaving 7,802 shares worth $629K. The position accounts for 0.96% of the portfolio, ranked #20.

Altar Rock first reported a position in TXG in Q4 2025 and has held it in 4 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Altar Rock held 7,802 shares of 10x Genomics worth $629K as of Q3 2026.
  • Altar Rock sold 2,744 10x Genomics shares in Q3 2026, an estimated $161K.
  • 10x Genomics made up 0.96% of Altar Rock's portfolio in Q3 2026, its #20 holding.
  • Altar Rock first reported a position in 10x Genomics in Q4 2025 and has held it in 4 quarters since.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Altar Rock's 13F filing for Q3 2026, filed 6 Nov 2026.